Chaetominine

Cat. No.: IBDI-434700

Chaetominine is an alkaloidal metabolite. Chaetominine has cytotoxicity against human leukemia K562 and colon cancer SW1116 cell lines. Chaetominine reduces MRP1-mediated agent resistance via inhibiting PI3K/Akt/Nrf2 signaling pathway in K562/Adr human leukemia cells.

Product Details

Target	PI3K | Akt | Keap1-Nrf2
Molecular Weight	402.40
Synonyms	(-)-Chaetominine
SMILES	O[[email protected]]1(C[[email protected]@]2([H])N(C=NC3=CC=CC=C43)C4=O)[[email protected]](N([[email protected]]5C)C2=O)([H])N(C5=O)C6=CC=CC=C16

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.